NCT04364607

IM Neostigmine for Accelerating Bladder Emptying After CS by Spinal Anesthesia

Intramuscular Neostigmine for Accelerating Bladder Emptying After Cesarean Section by Spinal Anesthesia

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: Mansoura University · Academic / Other
• Sex: Female
• Age: 20 Years – 35 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study is to assess the efficacy of IM neostigmine (0.5 mg) for acceleration of bladder evacuation and prevention of postoperative urine retention following cesarean delivery carried out under spinal anesthesia

Detailed description

Following cesarean delivery, women will receive either 0.5 mg IM neostigmine (study group) or IM NaCl 0.9% (control group). Bladder ultrasonography will be done every hour until spontaneous voiding occurs. If postoperative urine retention occurred (void inability with bladder volume \> 600 ml by ultrasound), urinary catheterization will be done.

Conditions

• Cesarean Section Complications

Interventions

Type	Name	Description
DRUG	Neostigmine	Participants will receive 0.5 mg IM neostigmine
DRUG	NaCl 0.9%	Participants will receive IM NaCl 0.9% as a placebo

Timeline

• Start date: 2020-08-05
• Primary completion: 2021-10-26
• Completion: 2021-10-26
• First posted: 2020-04-28
• Last updated: 2023-06-07

Locations

1 site across 1 country: Egypt